1、 Kanbay M, Segal M, Afsar B, et al. The role of uric acid in the pathogenesis of human cardiovascular disease[J]. Heart, 2013(99): 759-766. Kanbay M, Segal M, Afsar B, et al. The role of uric acid in the pathogenesis of human cardiovascular disease[J]. Heart, 2013(99): 759-766.
2、 Yu J, Han J, Mao J, et al. Association between serum uric acid level and the severity of coronary artery disease in patients with obstructive coronary artery disease[J]. Chin Med J (Engl), 2014,(127): 1039-1045. Yu J, Han J, Mao J, et al. Association between serum uric acid level and the severity of coronary artery disease in patients with obstructive coronary artery disease[J]. Chin Med J (Engl), 2014,(127): 1039-1045.
3、 Salehidoost R, Aminorroaya A, Zare M, et al. Is uric acid an indicator of metabolic syndrome in the first-degree relatives of patients with type 2 diabetes[J].J Res Med Sci, 2012,(17): 1005-1010. Salehidoost R, Aminorroaya A, Zare M, et al. Is uric acid an indicator of metabolic syndrome in the first-degree relatives of patients with type 2 diabetes[J].J Res Med Sci, 2012,(17): 1005-1010.
4、 Gill A, Kukreja S, Malhotra N, et al. Correlation of the serum insulin and the serum uric Acid levels with the glycated haemoglobin levels in the patients of type 2 diabetes mellitus[J]. J Clin Diagn Res, 2013,(7): 1295-1297. Gill A, Kukreja S, Malhotra N, et al. Correlation of the serum insulin and the serum uric Acid levels with the glycated haemoglobin levels in the patients of type 2 diabetes mellitus[J]. J Clin Diagn Res, 2013,(7): 1295-1297.
5、 Jiao Z, Gao HL, Li H, et al. Pre-diabetes mellitus influenced by hyperuricemia[J].Chinese Journal of Epidemiology, 2013, 34: 725-727. Jiao Z, Gao HL, Li H, et al. Pre-diabetes mellitus influenced by hyperuricemia[J].Chinese Journal of Epidemiology, 2013, 34: 725-727.
6、 Gustafsson D, Unwin R. The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality[J]. BMC Nephrol, 2013,(14): 164. Gustafsson D, Unwin R. The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality[J]. BMC Nephrol, 2013,(14): 164.
7、 Grundy SM, Balady GJ, Criqui MH, et al. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association[J]. Circulation, 1998,(97): 1876-1887. Grundy SM, Balady GJ, Criqui MH, et al. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association[J]. Circulation, 1998,(97): 1876-1887.
8、 胡大一, 余金明. 中国心血管病医生心血管疾病风险评估及心血管疾病预防的流行病学研究.中华医学会第11次心血管病学术会议[C]. 中国辽宁大连, 2009: 2. 胡大一, 余金明. 中国心血管病医生心血管疾病风险评估及心血管疾病预防的流行病学研究.中华医学会第11次心血管病学术会议[C]. 中国辽宁大连, 2009: 2.
9、 国家“十五”攻关“冠心病、脑卒中综合危险度评估及干预方案的研究”课题组. 国人缺血性心血管病发病危险的评估方法及简易评估工具的开发研究[J]. 中华心血管病杂志, 2003: 16-24. 国家“十五”攻关“冠心病、脑卒中综合危险度评估及干预方案的研究”课题组. 国人缺血性心血管病发病危险的评估方法及简易评估工具的开发研究[J]. 中华心血管病杂志, 2003: 16-24.
